Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma

Fig. 2

Expression of ZEB1 and ZEB2 in Kidney Renal Clear Cell Carcinoma (KIRC). A, ZEB1 expression in various types of cancer was determined using the Tumor Immune Estimation Resource (TIMER) database. B, ZEB2 expression in different types of cancer. C, D, Expression levels of ZEB1 (C) and ZEB2 (D) were evaluated in KIRCs and their corresponding adjacent normal tissues using the GSE40435 dataset. E, Promoter methylation levels of ZEB1 and ZEB2 in KIRC tissues and normal tissues were analyzed using UALCAN. F, The UALCAN database was utilized to examine the protein expressions of ZEB1 and ZEB2 in KIRC. Note: *P < 0.05; **P < 0.01; ***P < 0.001

Back to article page